Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vera

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 25, 2014
FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy dosesLamyaa Nkhali, Sébastien Thureau, Agathe Edet-Sanson, et al.
EJNMMI Physics|May 14, 2020
Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic imagesEdgar Texte, Pierrick Gouel, Sébastien Thureau, et al.
Oncoimmunology|May 10, 2019
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumabGeoffrey Popinat, Stéphanie Cousse, Lucas Goldfarb, et al.
Inflammatory Bowel Diseases|January 21, 2012
Magnetic resonance colonography in rats with TNBS-induced colitis: a feasibility and validation studyCloé Charpentier, Rachel Marion-Letellier, Guillaume Savoye, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
American Journal of Medical Genetics. Part A|November 10, 2005
Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotypeLucie Guyant-Maréchal, Aad Verrips, Carole Girard, et al.
EJNMMI Research|April 13, 2021
Angiogenesis imaging study using interim [<sup>18</sup>F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidenceDavid Tonnelet, M D Pierre Bohn, Stephanie Becker, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Synthesis and biological evaluation of a novel (99m)Tc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxiaYoann Joyard, Vadim Le Joncour, Hélène Castel, et al.
Plos One|March 11, 2017
Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifierPaul Desbordes, Su Ruan, Romain Modzelewski, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Acta Oncologica (Stockholm, Sweden)|November 25, 2014
FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy dosesLamyaa Nkhali, Sébastien Thureau, Agathe Edet-Sanson, et al.
EJNMMI Physics|May 14, 2020
Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic imagesEdgar Texte, Pierrick Gouel, Sébastien Thureau, et al.
Oncoimmunology|May 10, 2019
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumabGeoffrey Popinat, Stéphanie Cousse, Lucas Goldfarb, et al.
Inflammatory Bowel Diseases|January 21, 2012
Magnetic resonance colonography in rats with TNBS-induced colitis: a feasibility and validation studyCloé Charpentier, Rachel Marion-Letellier, Guillaume Savoye, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
American Journal of Medical Genetics. Part A|November 10, 2005
Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotypeLucie Guyant-Maréchal, Aad Verrips, Carole Girard, et al.
EJNMMI Research|April 13, 2021
Angiogenesis imaging study using interim [<sup>18</sup>F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidenceDavid Tonnelet, M D Pierre Bohn, Stephanie Becker, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Synthesis and biological evaluation of a novel (99m)Tc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxiaYoann Joyard, Vadim Le Joncour, Hélène Castel, et al.
Plos One|March 11, 2017
Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifierPaul Desbordes, Su Ruan, Romain Modzelewski, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Pageof 15